Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

701 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Deprescribing anticholinergics to preserve brain health: reducing the risk of dementia through deprescribing (R2D2): study protocol for a randomized clinical trial.
Campbell NL, Holden RJ, Gao S, Unverzagt FW, Lane KA, Carter A, Harrington AB, Manoharan S, Manoharan N, Rosenthal DL, Pitts C, Pelkey K, Papineau E, Lauck DM, Keshk N, Alamer K, Khalil H, Boustani MA. Campbell NL, et al. Among authors: harrington ab. Trials. 2024 Nov 22;25(1):788. doi: 10.1186/s13063-024-08618-4. Trials. 2024. PMID: 39578926 Free PMC article.
Deprescribing Anticholinergics to Preserve Brain Health: Reducing the Risk of Dementia through Deprescribing (R2D2): Study Protocol for a Randomized Clinical Trial.
Campbell NL, Holden RJ, Gao S, Unverzagt FW, Lane KA, Carter A, Harrington AB, Manoharan S, Manoharan N, Rosenthal DL, Pitts C, Pelkey K, Papineau E, Lauck DA, Keshk N, Alamer K, Khalil H, Boustani MA. Campbell NL, et al. Among authors: harrington ab. Res Sq [Preprint]. 2024 Oct 28:rs.3.rs-4682599. doi: 10.21203/rs.3.rs-4682599/v1. Res Sq. 2024. Update in: Trials. 2024 Nov 22;25(1):788. doi: 10.1186/s13063-024-08618-4 PMID: 39574889 Free PMC article. Updated. Preprint.
Time to Sustained Recovery Among Outpatients With COVID-19 Receiving Montelukast vs Placebo: The ACTIV-6 Randomized Clinical Trial.
Rothman RL, Stewart TG, Mourad A, Boulware DR, McCarthy MW, Thicklin F, Garcia Del Sol IT, Garcia JL, Bramante CT, Shah NS, Singh U, Williamson JC, Rebolledo PA, Jagannathan P, Schwasinger-Schmidt T, Ginde AA, Castro M, Jayaweera D, Sulkowski M, Gentile N, McTigue K, Felker GM, DeLong A, Wilder R, Collins S, Dunsmore SE, Adam SJ, Hanna GJ, Shenkman E, Hernandez AF, Naggie S, Lindsell CJ; Accelerating COVID-19 Therapeutic Interventions and Vaccines–6 Study Group and Investigators. Rothman RL, et al. JAMA Netw Open. 2024 Oct 1;7(10):e2439332. doi: 10.1001/jamanetworkopen.2024.39332. JAMA Netw Open. 2024. PMID: 39422912 Free PMC article. Clinical Trial.
701 results